9 July 2020

Considering the COVID-19 pandemic, the ENABLE team decided to postpone the Symposium to Spring 2021! 

The 4th European PhD and Postdoc symposium “EXPLORING LIFE DYNAMICS: In and out of equilibrium” will be held in Milan, Spring 2021. ENABLE aims to involve young scientists in opening the academic world from within by promoting crosstalk between biomedical disciplines, collaboration with industry, and engagement with society. The symposia are organized by and for young researchers and are inspiring events not to be missed!

Follow @EnableNetworkEU in social media (Twitter, Facebook, Instagram and LinkedIn) to stay updated on the
latest news of the event and save the date for ENABLE 2021 in Milan!

  • Want to know more about these subjects? Click on the buttons below for more news.

    RIMLS

Related news items


How are the Dutch Olympians prepared for the heat and humidity of Tokyo?

22 July 2021

Personal heat preparedness advice for Dutch Olympic athletes

read more

Nijmegen literally puts Digital Health on the map Flourishing ecosystem gets its own interactive overview

22 July 2021

Digital Health is thriving in the Nijmegen region, where it contributes to better care and health and also creates jobs. To bring developers and end users even closer together, The Economic Board and the Radboudumc are introducing the Interactive Digital Health map.

read more

Jeroen de Baaij Appointed associate professor

21 July 2021

Jeroen de Baaij, from the department of Physiology, has been appointed associate professor Kidney Physiology as of 1 August 2021.

read more

Michiel Vermeulen and Klaas Mulder receive funding from ZonMw for a collaborative project using stem cell-based models

15 July 2021

Michiel Vermeulen and Klaas Mulder, theme Cancer development and immune defense, receive funding from ZonMw for a collaborative project to develop a stem cell based model to study early human embryogenesis.

read more

Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development

15 July 2021

The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development Consortium

read more